Severe Toxic Epidermal Necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms Overlap Syndrome Treated with Benralizumab: A Case Report

Zeller, Felix K.; Bader, Patrick R.; Nägeli, Mirjam C.; Buehler, Philipp K.; Schuepbach, Reto A.

Zeller, Felix K.; Bader, Patrick R.; Nägeli, Mirjam C.; Buehler, Philipp K.; Schuepbach, Reto A..

Case Reports in Dermatology ; 14(2):203-209, 2022.

Article in English | ProQuest Central | ID: covidwho-2027180

ABSTRACT

ABSTRACT

TEN/DRESS overlap syndrome can be difficult to diagnose, especially if it is masked by comorbidities in critically ill patients in intensive care units. The existing therapy for the two conditions is also a major challenge for the treating team. A possible alternative, especially for refractory cases, is benralizumab as an IL-5-receptor alpha-chain-specific humanized monoclonal antibody (IgG1k). We are able to show a successful treatment in this case report.

Keywords

Medical Sciences--Dermatology And Venereology; Drug reaction with eosinophilia and systemic symptoms; Toxic epidermal necrolysis; Benralizumab; IL-5 blocker; Laboratories; Monoclonal antibodies; Patients; Severe acute respiratory syndrome coronavirus 2; Cytotoxicity; Liver; Mortality; Steroids; Biopsy; Lymphocytes; Severe acute respiratory syndrome; Skin; Inflammation; Conflicts of interest; Kidneys; Enzymes; Coronaviruses; Serology; Drug dosages; COVID-19

Search on Google

XML

Collection: Databases of international organizations Database: ProQuest Central Type of study: Case report Language: English Journal: Case Reports in Dermatology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML